Search Results
Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast Cancer
Dr. Mark Pegram on Combining Trastuzumab and Pertuzumab
Dr. Pegram Discusses Adjuvant Pertuzumab in HER2+ Breast Cancer
Dr. Pegram on Pertuzumab and Trastuzumab in Breast Cancer
Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast Cancer
Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast Cancer
Pertuzumab adds 16 months survival to trastuzumab plus chemo for HER2-positive breast cancer
Dr. Pegram on Margetuximab Plus Chemo in HER2+ Breast Cancer
Dr. Peter Beitsch on Pertuzumab in the Luminal Subtype of HER2-Positive Breast Cancer
Dr. Osborne on Pertuzumab in HER2+ Breast Cancer
Dr. Sanft on Treatment Options in HER2-Positive Breast Cancer
Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer
